State of Risk Management System
The Group has formulated risk management regulations and implements risk management with the aims of prevention, to prevent the occurrence of management risks themselves, and minimization of impact by understanding the situation and responding promptly and appropriately when risks occur. To ensure thorough risk management and compliance throughout the Group, the Company has established a Risk and Compliance Committee, which meets twice a year in principle. To ensure thorough risk management and compliance throughout the Group, the Company has established a Risk and Compliance Committee, which meets twice a year in principle.
Approach to Information Security
The Group engages in businesses related to life and maintaining health, and is often exposed to sensitive information in the medical field. Society requires the Group to exercise careful consideration and handling of such information.
We recognize that the safe and correct handling of information and the stable operation of systems are indispensable to providing higher quality services without compromising corporate value, and to ensure the continuity of our business.
Formulating an Information Security Policy
We have formulated the VITAL KSK Holdings Information Security Policy to further enhance safety and security and help Group employees to recognize the importance of information security. The Information Security Policy is a comprehensive, specific and systematic policy designed to protect information assets owned by the organization from threats. It outlines the Group’s basic approach to information security and policies on systems, organization and operation to ensure information security.
In accordance with the VITAL KSK Holdings Information Security Policy, the Group fulfills its social responsibilities by formulating internal rules and implementation standards in line with specific organizational units, data and information assets.
Major Risks and Group Responses
Major Risks | Risks | Group Responses< |
---|---|---|
Risks associated with natural disasters and accidents
|
|
|
Risks related to health insurance system reforms and the revision of drug price standards
|
|
|
Risks related to drug manufacturer price policies
|
|
|
Risks related to delivery prices
|
|
|
Risks associated with the ownership of investment securities
|
|
|
Compliance
|
|
|
Risks related to information leaks
|
|
|
Risks due to system problems
|
|
|
*Japan’s Ministry of Health, Labour and Welfare (MHLW) has been applying Guidelines for the Improvement of Commercial Transaction Practices of Ethical Drugs for Manufacturers, Wholesalers, and Medical Institutions/Pharmacies since April 2018.